Supporting caregivers during hematopoietic cell transplantation for children with primary immunodeficiency disorders - 06/06/19
Abstract |
Background |
Caregivers of children with primary immunodeficiency disorders (PIDs) experience significant psychological distress during their child's hematopoietic cell transplantation (HCT) process.
Objectives |
This study aims to understand caregiver challenges and identify areas for health care system-level improvements to enhance caregiver well-being.
Methods |
In this mixed-methods study caregivers of children with PIDs were contacted in August to November 2017 through online and electronic mailing lists of rare disease consortiums and foundations. Caregivers were invited to participate in an online survey assessing sociodemographic variables, the child's medical characteristics, psychosocial support use, and the World Health Organization–5 Well-Being Index. Open-ended questions about health care system improvements were included. Descriptive statistics and linear multivariate regression analyses were conducted. A modified content analysis method was used to code responses and identify emergent themes.
Results |
Among the 80 caregiver respondents, caregivers had a median age of 34 years (range, 23-62 years) and were predominantly female, white, and married with male children given a diagnosis of severe combined immune deficiency. In the adjusted regression model lower caregiver well-being was significantly associated with lower household income and medical complications. Challenges during HCT include maintaining relationships with partners and the child's healthy sibling or siblings, managing self-care, and coping with feelings of uncertainty. Caregivers suggested several organizational-level solutions to enhance psychosocial support, including respite services, online connections to other PID caregivers, and bedside mental health services.
Conclusions |
Certain high-risk subpopulations of caregivers might need more targeted psychosocial support to reduce the long-term effect of the HCT experience on their well-being. Caregivers suggested several organizational-level solutions for provision of this support.
Le texte complet de cet article est disponible en PDF.Key words : Hematopoietic cell transplantation, primary immune deficiency, caregiver, psychosocial support: well-being
Abbreviations used : HCT, PID, SCID
Plan
Disclosure of potential conflict of interest: J. Yoo was supported by funding from UCSF's Resource Allocation Program for Trainees. V. Yank was supported by funding from the National Institutes of Health (NIH; K23DK097308). M. J. Cowan is supported by funding from the NIH (U54 AI 082973) and the California Institute of Regenerative Medicine (CLIN2-09504 and CLIN2-10830). M. J. Dorsey is supported by funding from the National Institute of General Medical Sciences (R01GM107132). C. Mangurian was supported by funding from the NIH (K23MH093689), as well as by funding from the UCSF John A. Watson Faculty Scholarship. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 143 - N° 6
P. 2271-2278 - juin 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?